Wartość Opublikowane akcje organizacji FluroTech Ltd. to 120.686M
Akcje pozostające w obrocie(Shares outstanding) to wszystkie akcje spółki lub aktywa finansowego, które zostały autoryzowane, wyemitowane i nabyte przez inwestorów i są przez nie posiadane.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
FluroTech Ltd., a technology and marketing company, focuses on the commercialization of various technologies in the pandemic defense sector. It provides a pandemic defense platform, a saliva-based antigen test that targets active infections evidenced by the presence of live viral particles. The company is headquartered in Calgary, Canada.